Cargando…
Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature
BACKGROUND: Uterine sarcomas are relatively rare tumors that account for approximately 1-3% of female genital tract malignancies and between 4-9% of uterine cancers. Less than 8% of all cases are Mullerian adenosarcoma, a distinctive uterine neoplasm characterized by a benign, but occasionally atypi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141764/ https://www.ncbi.nlm.nih.gov/pubmed/21663687 http://dx.doi.org/10.1186/1471-2407-11-236 |
_version_ | 1782208751297626112 |
---|---|
author | Patrelli, Tito Silvio Gizzo, Salvatore Di Gangi, Stefania Guidi, Giorgia Rondinelli, Mario Nardelli, Giovanni Battista |
author_facet | Patrelli, Tito Silvio Gizzo, Salvatore Di Gangi, Stefania Guidi, Giorgia Rondinelli, Mario Nardelli, Giovanni Battista |
author_sort | Patrelli, Tito Silvio |
collection | PubMed |
description | BACKGROUND: Uterine sarcomas are relatively rare tumors that account for approximately 1-3% of female genital tract malignancies and between 4-9% of uterine cancers. Less than 8% of all cases are Mullerian adenosarcoma, a distinctive uterine neoplasm characterized by a benign, but occasionally atypical, epithelial and a malignant, usually low-grade, stromal component, both of which should be integral and neoplastic constituents of the tumor. Mullerian adenosarcoma with sarcomatous overgrowth (MASO) is a very aggressive variant, associated with post-operative recurrence, metastases, even when diagnosed in early stage. CASE PRESENTATION: We present a fourth MASO case derived from uterine cervix in a 72-year-old woman with metrorrhagia and a polypoid mass protruding through the cervical ostium. Total abdominal hysterectomy, bilateral salpingo-oophorectomy, systematic pelvic lymph node dissection, omental biopsy and appendectomy were performed. Surgery treatment was associated with adjuvant whole-pelvis radiation (45 Gy) and adjuvant chemotherapy (cisplatin/ifosfamide). After nine months of follow up, the patient was free of tumor. CONCLUSIONS: The rarity of MASO of the cervix involves a management difficult. Most authors recommend total abdominal hysterectomy, usually accompanied by bilateral salpingo-oophorectomy. There is no common agreement on staging by lymphadenectomy during primary surgery and adjuvant chemo-radio therapy. |
format | Online Article Text |
id | pubmed-3141764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31417642011-07-23 Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature Patrelli, Tito Silvio Gizzo, Salvatore Di Gangi, Stefania Guidi, Giorgia Rondinelli, Mario Nardelli, Giovanni Battista BMC Cancer Case Report BACKGROUND: Uterine sarcomas are relatively rare tumors that account for approximately 1-3% of female genital tract malignancies and between 4-9% of uterine cancers. Less than 8% of all cases are Mullerian adenosarcoma, a distinctive uterine neoplasm characterized by a benign, but occasionally atypical, epithelial and a malignant, usually low-grade, stromal component, both of which should be integral and neoplastic constituents of the tumor. Mullerian adenosarcoma with sarcomatous overgrowth (MASO) is a very aggressive variant, associated with post-operative recurrence, metastases, even when diagnosed in early stage. CASE PRESENTATION: We present a fourth MASO case derived from uterine cervix in a 72-year-old woman with metrorrhagia and a polypoid mass protruding through the cervical ostium. Total abdominal hysterectomy, bilateral salpingo-oophorectomy, systematic pelvic lymph node dissection, omental biopsy and appendectomy were performed. Surgery treatment was associated with adjuvant whole-pelvis radiation (45 Gy) and adjuvant chemotherapy (cisplatin/ifosfamide). After nine months of follow up, the patient was free of tumor. CONCLUSIONS: The rarity of MASO of the cervix involves a management difficult. Most authors recommend total abdominal hysterectomy, usually accompanied by bilateral salpingo-oophorectomy. There is no common agreement on staging by lymphadenectomy during primary surgery and adjuvant chemo-radio therapy. BioMed Central 2011-06-11 /pmc/articles/PMC3141764/ /pubmed/21663687 http://dx.doi.org/10.1186/1471-2407-11-236 Text en Copyright ©2011 Patrelli et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Patrelli, Tito Silvio Gizzo, Salvatore Di Gangi, Stefania Guidi, Giorgia Rondinelli, Mario Nardelli, Giovanni Battista Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature |
title | Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature |
title_full | Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature |
title_fullStr | Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature |
title_full_unstemmed | Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature |
title_short | Cervical Mullerian Adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature |
title_sort | cervical mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141764/ https://www.ncbi.nlm.nih.gov/pubmed/21663687 http://dx.doi.org/10.1186/1471-2407-11-236 |
work_keys_str_mv | AT patrellititosilvio cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature AT gizzosalvatore cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature AT digangistefania cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature AT guidigiorgia cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature AT rondinellimario cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature AT nardelligiovannibattista cervicalmullerianadenosarcomawithheterologoussarcomatousovergrowthafourthcaseandreviewofliterature |